Page last updated: 2024-11-05

zonisamide and Epilepsy Syndromes

zonisamide has been researched along with Epilepsy Syndromes in 1 studies

Zonisamide: A benzisoxazole and sulfonamide derivative that acts as a CALCIUM CHANNEL blocker. It is used primarily as an adjunctive antiepileptic agent for the treatment of PARTIAL SEIZURES, with or without secondary generalization.
zonisamide : A 1,2-benzoxazole compound having a sulfamoylmethyl substituent at the 3-position.

Research Excerpts

ExcerptRelevanceReference
"In five cases, tonic seizures preceded spasms at a median age of 6 weeks."1.51New insights in phenomenology and treatment of epilepsy in CDKL5 encephalopathy. ( Bienvenu, T; Chikvinidze, G; Dulac, O; Epitashvili, N; Gataullina, S; Melikishvili, G; Tabatadze, N, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Melikishvili, G1
Epitashvili, N1
Tabatadze, N1
Chikvinidze, G1
Dulac, O1
Bienvenu, T1
Gataullina, S1

Other Studies

1 other study available for zonisamide and Epilepsy Syndromes

ArticleYear
New insights in phenomenology and treatment of epilepsy in CDKL5 encephalopathy.
    Epilepsy & behavior : E&B, 2019, Volume: 94

    Topics: Anticonvulsants; Child; Child, Preschool; Drug Therapy, Combination; Electroencephalography; Electro

2019